Biotech Startups

ShanX Medtech develops a diagnostic platform that identifies bacterial infections and determines antibiotic susceptibility from patient samples within approximately one hour. The system serves clinicians in hospital microbiology labs and point-of-care settings, providing targeted treatment guidance based on individual patient needs.

2 investors

Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19. It works to address global health challenges such as antimicrobial resistance, partnering with industry, government agencies, and early-stage biotechs.

2 investors

Shorla Oncology develops pharmaceutical products to address unmet needs in oncology. The company was founded by healthcare entrepreneurs with extensive experience in the pharmaceutical industry and regulatory affairs.

2 investors

Sidera Bio is a biotechnology company using human genetics to develop new medicines for patients.

2 investors

Signant Health provides software platforms and clinical trial solutions for life sciences companies to manage patient-reported outcomes, evidence generation, and digital endpoints in drug development programs across multiple therapeutic areas.

2 investors

Silicozyme develops customizable enzymatic toolkits for biologics refinement and general processing applications. Its enzymes are engineered for performance, stability, and resilience to serve industrial and biotech processing needs.

2 investors

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.

2 investors

Singular Medical develops implantable cardiac devices and digital health solutions for arrhythmia and heart failure management, including pacemakers, defibrillators, and remote monitoring systems. The company serves hospitals and patients in China and developing markets with products spanning screening, diagnosis, treatment, and monitoring across implant and AI domains.

2 investors

Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples. Aimed at oncologists, the technology supports early cancer detection, monitoring of recurrence and treatment resistance, and personalised therapy selection for metastatic and aggressive cancers.

2 investors

Sirius Therapeutics is a biopharmaceutical company developing siRNA-based therapeutics, including work in the anti-coagulant therapeutic area. It focuses on drug discovery and clinical development of RNA-based medicines.

2 investors

SiSaf is an RNA delivery and therapeutics company that uses its proprietary bioabsorbable silicon-based Bio-Courier technology to deliver nucleic acids, avoiding the ultra-cold supply chain of conventional lipid nanoparticles. It is developing a pipeline of RNA therapeutics targeting pancreatic cancer, metastatic cancer, and the rare skeletal disease osteopetrosis ADO2.

2 investors

Slate Bio develops regulatory T cell (Treg) therapies for treating autoimmune diseases. The company focuses on advancing immunology treatments for patients with autoimmune conditions.

2 investors

Slate Medicines is a clinical-stage biotechnology company. The page profiles an executive but provides limited detail on the company's specific therapeutic focus.

2 investors

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring. Its products target clinicians, pharmaceutical companies, and researchers in medical oncology and precision medicine.

2 investors

Smart Cells stores and processes umbilical cord blood and tissue containing stem cells for families in the UK, offering banking services for potential future medical use. The company is part of Europe's largest stem cell bank and operates with full regulatory licensing and approval.

2 investors

Sobrera Pharma is a life science pharmaceutical company developing treatments for alcohol abuse, founded by researchers and clinicians from the Sahlgrenska Academy, University of Gothenburg.

2 investors

Sofinnova Partners is a venture capital and private investment firm that invests across multiple strategies including biotech, digital health, industrial biotechnology, and capital markets. The firm manages multiple specialized investment strategies focused on life sciences and healthcare innovation.

2 investors

Solabia is a producer of raw materials including ingredients, active ingredients, culture media, and diagnostic kits for the cosmetics, pharmaceutical, nutraceutical, and biotechnology industries. The group serves manufacturers in these sectors with a focus on innovation, sustainability, and responsible growth.

2 investors

Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.

2 investors

Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.

2 investors

2 investors

Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.

2 investors

Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies. A spin-off from CeMM/ÖAW and IST Austria, it focuses on advancing a pipeline of SLC-targeting compounds toward clinical development for human disease.

2 investors

Solis Agrosciences is an agricultural science company with a team focused on molecular sciences, plant transformation, and plant research. It employs scientists and research associates working in areas such as greenhouse work and plant biotechnology.

2 investors